UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies

Cancers, 2023-12, Vol.15 (24), p.5841

2023

Volltextzugriff (PDF)

Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors

Oncoimmunology, 2018-11, Vol.7 (11), p.e1507670-e1507670

2018

Volltextzugriff (PDF)

Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2018-09, Vol.67 (9), p.1365-1370

2018

Volltextzugriff (PDF)

Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell Disease

The New England journal of medicine, 2019-02, Vol.380 (9), p.887-888

2019

Volltextzugriff (PDF)

Applicability of and potential barriers preventing allogeneic stem cell transplant in sickle cell patients treated outside a sickle cell program

American journal of hematology, 2018-06, Vol.93 (6), p.E150-E152

2018

Volltextzugriff (PDF)

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Cancer, 2024-02, Vol.130 (3), p.400-409

2024

Volltextzugriff (PDF)

RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study

Molecular cancer, 2024-03, Vol.23 (1), p.64-64, Article 64

2024

Volltextzugriff (PDF)

Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies

Journal of Immunotherapy and Precision Oncology, 2024-05, Vol.7 (2), p.73-81

2024

Volltextzugriff (PDF)

Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma

American journal of hematology, 2019-03, Vol.94 (3), p.E74-E76

2019

Volltextzugriff (PDF)

Learning From Failure: Negative Trials in Oncology

Journal of Immunotherapy and Precision Oncology, 2023-05, Vol.6 (2), p.59-60

2023

Volltextzugriff (PDF)

Late‐onset fever and engraftment syndrome following autologous stem cell transplant: Impact on resource utilization

American journal of hematology, 2018-10, Vol.93 (10), p.E336-E338

2018

Volltextzugriff (PDF)

584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A664-A664

2023

Volltextzugriff (PDF)

Unique presentation of occult breast cancer with uterine cervix metastasis

Clinical case reports, 2019-08, Vol.7 (8), p.1573-1576

2019

Volltextzugriff (PDF)

The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia

Blood, 2021-11, Vol.138 (Supplement 1), p.2148-2148

2021

Volltextzugriff (PDF)

Blood-based multi-cancer detection: A state-of-the-art update

Current problems in cancer, 2024-02, Vol.48, p.101059-101059, Article 101059

2024

Volltextzugriff (PDF)

Evidence-Based Diagnosis and Physiotherapy Management of Musculoskeletal Disorders of Cervical Spine

International journal of health sciences and research, 2021-10, Vol.11 (10), p.145-157

2021

Volltextzugriff (PDF)

In-Hospital Outcomes in Elderly Acute Myeloid Leukemia (AML) Receiving Aggressive Inpatient Care: An Analysis of National Inpatient Sample (NIS) Database between Years 2005 and 2014

Blood, 2019-11, Vol.134 (Supplement_1), p.2149-2149

2019

Volltextzugriff (PDF)

Geographic distribution of clinical trials for breast cancer across the United States, 2011-2015

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.140-140

2019

Volltextzugriff (PDF)

RAF-inhibitor rechallenge therapy in BRAF aberrated pan-cancers: RE-RAFFLE study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3105-3105

2023

Volltextzugriff (PDF)

Predictors of survival outcomes in patients (pts) with advanced solid tumors treated with cellular therapies in early clinical trials

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14532-e14532

2023

Volltextzugriff (PDF)

Progress in determining response to treatment in gastrointestinal stromal tumor

Expert review of anticancer therapy, 2020-04, Vol.20 (4), p.279-288

2020

Volltextzugriff (PDF)

Outcomes of in-hospital cardiopulmonary resuscitation (ICPR) for cardiac arrest in adult patients with metastatic solid cancers: A nationwide inpatient sample (NIS) database analysis from 2012 to 2014

Journal of clinical oncology, 2019-11, Vol.37 (31_suppl), p.44-44

2019

Volltextzugriff (PDF)

Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine

JCO precision oncology, 2024-07, Vol.8 (8), p.e2400038

2024

Volltextzugriff (PDF)

Abstract 1250: Activating PIK3CA mutations and hedgehog signaling may confer resistance to KRAS inhibition in colorectal cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1250-1250

2024

Volltextzugriff (PDF)

Intrapatient comparative efficacy of selective RET inhibitors using growth modulation index in patients with RET aberrant cancers

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3086-3086

2023

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies

Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors

Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer

Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell Disease

Applicability of and potential barriers preventing allogeneic stem cell transplant in sickle cell patients treated outside a sickle cell program

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study

Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies

Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma

Learning From Failure: Negative Trials in Oncology

Late‐onset fever and engraftment syndrome following autologous stem cell transplant: Impact on resource utilization

584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

Unique presentation of occult breast cancer with uterine cervix metastasis

The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia

Blood-based multi-cancer detection: A state-of-the-art update

Evidence-Based Diagnosis and Physiotherapy Management of Musculoskeletal Disorders of Cervical Spine

In-Hospital Outcomes in Elderly Acute Myeloid Leukemia (AML) Receiving Aggressive Inpatient Care: An Analysis of National Inpatient Sample (NIS) Database between Years 2005 and 2014

Geographic distribution of clinical trials for breast cancer across the United States, 2011-2015

RAF-inhibitor rechallenge therapy in BRAF aberrated pan-cancers: RE-RAFFLE study

Predictors of survival outcomes in patients (pts) with advanced solid tumors treated with cellular therapies in early clinical trials

Progress in determining response to treatment in gastrointestinal stromal tumor

Outcomes of in-hospital cardiopulmonary resuscitation (ICPR) for cardiac arrest in adult patients with metastatic solid cancers: A nationwide inpatient sample (NIS) database analysis from 2012 to 2014

Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine

Abstract 1250: Activating PIK3CA mutations and hedgehog signaling may confer resistance to KRAS inhibition in colorectal cancer

Intrapatient comparative efficacy of selective RET inhibitors using growth modulation index in patients with RET aberrant cancers

Suchergebnisse filtern